Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Feb;10(1):11-8.
doi: 10.1034/j.1600-0625.2001.100102.x.

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

Affiliations
Comparative Study

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

J M Hanifin et al. Exp Dermatol. 2001 Feb.

Abstract

Objective: To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency.

Design: Training of evaluators, application, and assessment over 2 consecutive days.

Setting: An academic center.

Patients: Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients > or = 8 years) and cohort 2 (10 patients < 8 years).

Interventions: None.

Main outcome measure: The EASI was used by 15 dermatologist evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed.

Results: Overall intra-evaluator reliability of the EASI was in the fair-to-good range. Inter-evaluator reliability analyses indicated that the evaluators assessed the patients consistently across both study days.

Conclusions: This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.

PubMed Disclaimer

Similar articles

Cited by